Completed
8-Week Study of Tolvaptan Dose Forms in Autosomal Dominant Polycystic Kidney Disease (ADPKD)
NCT01451827
- Conditions
- Abnormalities, Multiple, Autosomal Dominant Polycystic Kidney Disease, Ciliopathies, +12 more
- Locations
-
- Otsuka Investigational Site Huntsville, Alabama, United States
- Otsuka Investigational Site Mobile, Alabama, United States
- Otsuka Investigational Site Peoria, Arizona, United States
- Otsuka Investigational Site Tempe, Arizona, United States